Scientific evidence published by health professionals around the world indicates an increased risk to develop Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) in children of women who took Tylenol during pregnancy.
Recent scientific research conducted by top institutions and universities around the world have found that Acetaminophen exposure during pregnancy may increase a child’s risk of Attention Deficit Hyperactivity Disorder (ADHD).
Lawsuits are being filed against the drug manufacturers and distributors of Tylenol and Generic Acetaminophen.
Johns Hopkins University Study on Acetaminophen Exposure During Pregnancy
In October 2019, researchers from Johns Hopkins University published a study in the JAMA Psychiatry Journal, titled:
In the publication, Johns Hopkins University researchers studied the cord blood samples of children whose mothers took Tylenol during pregnancy, sourcing data from 996 mother-child pairs in the Boston Birth Cohort.
The Johns Hopkins University researchers found that:
“Cord plasma biomarkers of fetal exposure to acetaminophen were associated with significantly increased risk of childhood attention-deficit/hyperactivity disorder and autism spectrum disorder.”
Significant data points in the Johns Hopkins University study are as follows:
- 25.8% of the children studied were diagnosed with ADHD only
- 6.6% of the children studied were diagnosed with ASD only
- 4.2% of the children were diagnosed with both ADHD and ASD
- 30.5% of the children were diagnosed with other developmental disorders
- 32.8% of the children were neurotypical
2018 Study Published in the American Journal of Epidemiology
Another study conducted on the association of Acetaminophen exposure and neurodevelopmental disorders found similar results, warning expectant mothers of the potential dangers of the drug.
Researchers from a host of countries across North America, Europe and South America published the study, titled:
In this study, researchers found that children exposed to acetaminophen during pregnancy experienced:
- A 20% higher associated risk of autism (ASD); and
- A 30% higher associated risk of ADHD
Health Professionals Warn that In-Utero Acetaminophen Exposure May Be Linked to ASD and ADHD
In September 2021, researchers and health professionals published a consensus statement titled “Paracetamol use during pregnancy — a call for precautionary action“.
Their consensus statement warns the public that paracetamol, the active ingredient in Tylenol and acetaminophen, may alter fetal development.
The researchers state that rates of developmental disorders, neurological disorders, and other urogenital and reproductive disorders have been rising.
They further state that:
“… [These outcomes] have been associated with maternal and perinatal use of paracetamol (APAP).”
